Literature DB >> 18915673

The treatment of rheumatic polyarthritis with acid azo compounds.

N SVARTZ.   

Abstract

Entities:  

Keywords:  ARTHRITIS/therapy; CARBOHYDRATES/metabolism

Mesh:

Substances:

Year:  1948        PMID: 18915673

Source DB:  PubMed          Journal:  Rheumatism        ISSN: 0370-5250


× No keyword cloud information.
  17 in total

1.  Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.

Authors:  M Farr; A Brodrick; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

Review 2.  The microbiome and rheumatoid arthritis.

Authors:  Jose U Scher; Steven B Abramson
Journal:  Nat Rev Rheumatol       Date:  2011-08-23       Impact factor: 20.543

3.  Salazopyrin in rheumatoid arthritis.

Authors:  B McConkey; R S Amos; E P Butler; R A Crockson; A P Crockson; L Walsh
Journal:  Agents Actions       Date:  1978-06

4.  History of the development of sulphasalazine in rheumatology.

Authors:  B McConkey
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Salazopyrin in rheumatoid arthritis. 1978.

Authors:  B McConkey; R S Amos; E P Butler; R A Crockson; A P Crockson; L Walsh
Journal:  Agents Actions       Date:  1994-12

Review 6.  Sulfasalazine for rheumatoid arthritis.

Authors:  M E Suarez-Almazor; E Belseck; B Shea; G Wells; P Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 7.  New perspectives of secondary and tertiary therapy for rheumatoid arthritis.

Authors:  R F Willkens
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 8.  Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.

Authors:  Jose U Scher; Dan R Littman; Steven B Abramson
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

9.  The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.

Authors:  M Farr; E Tunn; A P Crockson; P A Bacon
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

Review 10.  Disease-modifying antirheumatic drugs. Potential effects in older patients.

Authors:  G Gardner; D E Furst
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.